AR and cancer: It may be possible that PCAN1 is negatively regulated by androgens and NKX3.1 compensates this effect through positively regulating PCAN1. In addition, AR, NKX3.1 and PCAN1 play different roles in prostate development and cancer, and their interactions in prostate are very complicated and need further to be investigated.